FRAIZERON Trademark

Trademark Overview

On Tuesday, September 1, 2009, a trademark application was filed for FRAIZERON with the United States Patent and Trademark Office. The USPTO has given the FRAIZERON trademark a serial number of 79074182. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Sunday, July 29, 2018. This trademark is owned by NOVARTIS AG. The FRAIZERON trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention or treatment of diseases and disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases, for the treatment of bacteria-based diseases and disorders, autoimmune diseases or disorders, kidney diseases or disorders and diabetes; antifungal preparations anti-infectives, antivirals and antibiotics
fraizeron

General Information

Serial Number79074182
Word MarkFRAIZERON
Filing DateTuesday, September 1, 2009
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSunday, July 29, 2018
Registration Number3811160
Registration DateTuesday, June 29, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 13, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention or treatment of diseases and disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases, for the treatment of bacteria-based diseases and disorders, autoimmune diseases or disorders, kidney diseases or disorders and diabetes; antifungal preparations anti-infectives, antivirals and antibiotics
Translation of Words in MarkThe wording "FRAIZERON" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateMonday, October 26, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH
Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH
Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events

Event DateEvent Description
Saturday, February 16, 2019NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Saturday, February 16, 2019DEATH OF INTERNATIONAL REGISTRATION
Friday, November 18, 2016NOTIFICATION PROCESSED BY IB
Monday, November 16, 2015NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Sunday, November 15, 2015DEATH OF INTERNATIONAL REGISTRATION
Monday, April 15, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, April 13, 2013NEW REPRESENTATIVE AT IB RECEIVED
Saturday, February 23, 2013CHANGE OF NAME/ADDRESS REC'D FROM IB
Wednesday, October 20, 2010FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, October 20, 2010FINAL DISPOSITION PROCESSED
Thursday, September 30, 2010FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, September 29, 2010CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Saturday, September 18, 2010CORRECTION TRANSACTION RECEIVED FROM IB
Tuesday, June 29, 2010REGISTERED-PRINCIPAL REGISTER
Tuesday, April 13, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 13, 2010PUBLISHED FOR OPPOSITION
Saturday, March 6, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, March 6, 2010ASSIGNED TO LIE
Friday, February 12, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 4, 2010EXAMINER'S AMENDMENT ENTERED
Thursday, February 4, 2010NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, February 4, 2010EXAMINERS AMENDMENT E-MAILED
Thursday, February 4, 2010EXAMINERS AMENDMENT -WRITTEN
Tuesday, February 2, 2010ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 2, 2010TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, January 22, 2010REFUSAL PROCESSED BY IB
Wednesday, December 9, 2009NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, December 9, 2009REFUSAL PROCESSED BY MPU
Tuesday, December 8, 2009NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, December 7, 2009NON-FINAL ACTION WRITTEN
Saturday, December 5, 2009ASSIGNED TO EXAMINER
Wednesday, November 11, 2009APPLICATION FILING RECEIPT MAILED
Saturday, November 7, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, November 6, 2009LIMITATION OF GOODS/SERVICES FROM IB ENTERED
Thursday, November 5, 2009SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Related Keywords

fraizeron system disorders diseases preparations treatment pharmaceutical prevention bacteria based ophthalmology